{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:40:23Z","timestamp":1792240823584,"version":"4.4.0"},"reference-count":95,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cystic Fibrosis is a chronic disease affecting multiple systems, including the GI tract. Clinical manifestation in patients can start as early as infancy and vary across different age groups. With the advent of new, highly effective modulators, the life expectancy of PwCF has improved significantly. Various GI aspects of CF care, such as nutrition, are linked to an overall improvement in morbidity, lung function and the quality of life of PwCF. The variable clinical presentations and management of GI diseases in pediatrics and adults with CF should be recognized. Therefore, it is necessary to ensure efficient transfer of information between pediatric and adult providers for proper continuity of management and coordination of care at the time of transition. The transition of care is a challenging process for both patients and providers and currently there are no specific tools for GI providers to help ensure a smooth transition. In this review, we aim to highlight the crucial features of GI care at the time of transition and provide a checklist that can assist in ensuring an effective transition and ease the challenges associated with it.<\/jats:p>","DOI":"10.3390\/ijms242115766","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:50:42Z","timestamp":1698670242000},"page":"15766","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Gastroenterologist\u2019s Guide to Care Transitions in Cystic Fibrosis from Pediatrics to Adult Care"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-0814","authenticated-orcid":false,"given":"Dhiren","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cardinal Glennon Children\u2019s Medical Center, Saint Louis University School of Medicine, St. Louis, MO 63104, USA"},{"name":"The AHEAD Institute, Saint Louis University School of Medicine, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Baliss","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavithra","family":"Saikumar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cardinal Glennon Children\u2019s Medical Center, Saint Louis University School of Medicine, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6162-2821","authenticated-orcid":false,"given":"Laith","family":"Numan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Teckman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cardinal Glennon Children\u2019s Medical Center, Saint Louis University School of Medicine, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hachem","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO 63104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Scotet, V., L\u2019Hostis, C., and F\u00e9rec, C. (2020). The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes, 11.","DOI":"10.3390\/genes11060589"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/ppul.25733","article-title":"Increasing life expectancy in cystic fibrosis: Advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1542\/peds.2009-2791","article-title":"Cystic fibrosis and transition to adult medical care","volume":"125","author":"Tuchman","year":"2010","journal-title":"Pediatrics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1002\/ppul.23778","article-title":"Overcoming barriers to a successful transition from pediatric to adult care","volume":"52","author":"Goralski","year":"2017","journal-title":"Pediatr. Pulmonol."},{"key":"ref_5","unstructured":"Transition, G. (2022, September 15). Got Transition. The Six Core Elements of Health Care Transition. Available online: http:\/\/www.gottransition.org\/providers\/index.cfm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/ped.2015.0594","article-title":"CF RISE: Implementing a Clinic-Based Transition Program","volume":"28","author":"Baker","year":"2015","journal-title":"Pediatr. Allergy Immunol. Pulmonol."},{"key":"ref_7","first-page":"481","article-title":"Gastro-intestinal manifestations in cystic fibrosis patients","volume":"79","author":"Declercq","year":"2016","journal-title":"Acta Gastroenterol. Belg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3109\/00365529108998565","article-title":"Gastro-oesophageal reflux and severity of pulmonary disease in cystic fibrosis","volume":"26","author":"Gustafsson","year":"1991","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ppul.21598","article-title":"The impact of reflux burden on Pseudomonas positivity in children with Cystic Fibrosis","volume":"47","author":"Palm","year":"2012","journal-title":"Pediatric. Pulmonol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ajg.2012.213","article-title":"Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis","volume":"107","author":"Pauwels","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","first-page":"100","article-title":"The association of cystic fibrosis, gastroesophageal reflux, and reduced pulmonary function","volume":"39","author":"Stringer","year":"1988","journal-title":"Can. Assoc. Radiol. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.paed.2020.07.002","article-title":"Gastrointestinal complications of cystic fibrosis","volume":"30","author":"Ng","year":"2020","journal-title":"Paediatr. Child Health"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ccm.2015.11.004","article-title":"Gastrointestinal Disorders in Cystic Fibrosis","volume":"37","author":"Assis","year":"2016","journal-title":"Clin. Chest Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jcf.2017.07.007","article-title":"Cystic Fibrosis and gastroesophageal reflux disease","volume":"16","author":"Maqbool","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1440-1754.1998.00159.x","article-title":"Bowel dysfunction in cystic fibrosis: Importance of breath testing","volume":"34","author":"Lewindon","year":"1998","journal-title":"J. Paediatr. Child Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11894-012-0261-9","article-title":"Gastroesophageal reflux in cystic fibrosis: Current understandings of mechanisms and management","volume":"14","author":"Mousa","year":"2012","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6322","DOI":"10.3748\/wjg.v26.i41.6322","article-title":"Focus on gastroesophageal reflux disease in patients with cystic fibrosis","volume":"26","author":"Bongiovanni","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcf.2021.05.016","article-title":"Review of Gastrointestinal Motility in Cystic Fibrosis","volume":"20","author":"Henen","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s10620-012-2209-1","article-title":"Intestinal pH and gastrointestinal transit profiles in cystic fibrosis patients measured by wireless motility capsule","volume":"58","author":"Gelfond","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1378\/chest.11-1573","article-title":"Bile acids in sputum and increased airway inflammation in patients with cystic fibrosis","volume":"141","author":"Pauwels","year":"2012","journal-title":"Chest"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/00365521.2012.699548","article-title":"Gastrointestinal transit times and motility in patients with cystic fibrosis","volume":"47","author":"Hedsund","year":"2012","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2918139","DOI":"10.1155\/2016\/2918139","article-title":"Is Gastroparesis Found More Frequently in Patients with Cystic Fibrosis? A Systematic Review","volume":"2016","author":"Corral","year":"2016","journal-title":"Scientifica"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MPG.0b013e3181b7f563","article-title":"Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN)","volume":"49","author":"Vandenplas","year":"2009","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s10620-009-0725-4","article-title":"Azithromycin reduces gastroesophageal reflux and aspiration in lung transplant recipients","volume":"54","author":"Mertens","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jpedsurg.2007.03.030","article-title":"Outcomes of fundoplication in children with cystic fibrosis","volume":"42","author":"Boesch","year":"2007","journal-title":"J. Pediatr. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/ppul.22630","article-title":"Outcomes of surgical management of severe GERD in patients with cystic fibrosis","volume":"48","author":"Sheikh","year":"2013","journal-title":"Pediatr. Pulmonol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gut.2007.146134","article-title":"Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosis","volume":"57","author":"Blondeau","year":"2008","journal-title":"Gut"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.jcf.2017.06.009","article-title":"Approach to chronic abdominal pain in Cystic Fibrosis","volume":"16","author":"Lusman","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcf.2018.11.005","article-title":"Cystic fibrosis is associated with an increased risk of Barrett\u2019s esophagus","volume":"18","author":"Knotts","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MPG.0b013e31802c0ceb","article-title":"Risk factors for small bowel bacterial overgrowth in cystic fibrosis","volume":"44","author":"Fridge","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_31","first-page":"631","article-title":"Small intestine bacterial overgrowth is frequent in cystic fibrosis: Combined hydrogen and methane measurements are required for its detection","volume":"56","author":"Lisowska","year":"2009","journal-title":"Acta Biochim. Pol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcf.2017.07.014","article-title":"Bacterial overgrowth, dysbiosis, inflammation, and dysmotility in the Cystic Fibrosis intestine","volume":"16","author":"Dorsey","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1155\/2011\/604643","article-title":"Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure","volume":"25","author":"Malik","year":"2011","journal-title":"Can. J. Gastroenterol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/jgh.12546","article-title":"Cystic fibrosis: An update for clinicians. Part 1: Nutrition and gastrointestinal complications","volume":"29","author":"Haller","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"G577","DOI":"10.1152\/ajpgi.00195.2007","article-title":"Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and inflammation in the cystic fibrosis mouse small intestine","volume":"293","author":"Roach","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1053\/j.gastro.2005.11.046","article-title":"Small intestinal bacterial overgrowth: Roles of antibiotics, prebiotics, and probiotics","volume":"130","author":"Quigley","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Dethlefsen, L., Huse, S., Sogin, M.L., and Relman, D.A. (2008). The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol., 6.","DOI":"10.1371\/journal.pbio.0060280"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/apt.12479","article-title":"Meta-analysis: Antibiotic therapy for small intestinal bacterial overgrowth","volume":"38","author":"Shah","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00535-018-1509-4","article-title":"The role of small intestinal bacterial overgrowth in cystic fibrosis: A randomized case-controlled clinical trial with rifaximin","volume":"54","author":"Furnari","year":"2019","journal-title":"J. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/bmj.287.6398.1011","article-title":"Prolonged small-intestinal transit time in cystic fibrosis","volume":"287","author":"Bali","year":"1983","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00005176-199202000-00015","article-title":"Intestinal permeability to 51Cr-EDTA and orocecal transit time in cystic fibrosis","volume":"14","author":"Escobar","year":"1992","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_42","unstructured":"Report, A.D. (2022, September 15). Annual Data Report 2020 Cystic Fibrosis Foundation Patient Registry. Available online: https:\/\/www.cff.org\/sites\/default\/files\/2021-10\/2019-Patient-Registry-Annual-Data-Report.pdf."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/MPG.0b013e3181a6e01d","article-title":"Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS","volume":"50","author":"Houwen","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jcf.2016.02.002","article-title":"International prospective study of distal intestinal obstruction syndrome in cystic fibrosis: Associated factors and outcome","volume":"15","author":"Munck","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1569-1993(11)60005-2","article-title":"Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients","volume":"10","author":"Colombo","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/0884533614551838","article-title":"Nutrition and pancreatic enzyme intake in patients with cystic fibrosis with distal intestinal obstruction syndrome","volume":"30","author":"Declercq","year":"2015","journal-title":"Nutr. Clin. Pract."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/00005176-199010000-00012","article-title":"The age-related incidence of meconium ileus equivalent in a cystic fibrosis population: The impact of high-energy intake","volume":"11","author":"Andersen","year":"1990","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archsurg.143.6.601","article-title":"Distal intestinal obstructive syndrome in adults with cystic fibrosis: A surgical perspective","volume":"143","author":"Speck","year":"2008","journal-title":"Arch. Surg."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1345\/aph.1Q219","article-title":"Lubiprostone for constipation in adults with cystic fibrosis: A pilot study","volume":"45","author":"Anderson","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MPG.0000000000000266","article-title":"Evaluation and treatment of functional constipation in infants and children: Evidence-based recommendations from ESPGHAN and NASPGHAN","volume":"58","author":"Tabbers","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1345\/aph.1M642","article-title":"Use of the chloride channel activator lubiprostone for constipation in adults with cystic fibrosis: A case series","volume":"44","author":"Anderson","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"G868","DOI":"10.1152\/ajpgi.00261.2017","article-title":"Linaclotide improves gastrointestinal transit in cystic fibrosis mice by inhibiting sodium\/hydrogen exchanger 3","volume":"315","author":"McHugh","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","article-title":"Pancreatic insufficiency in Cystic Fibrosis","volume":"16","author":"Singh","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/MEG.0b013e3282f36d04","article-title":"The changing face of the exocrine pancreas in cystic fibrosis: The correlation between pancreatic status, pancreatitis and cystic fibrosis genotype","volume":"20","author":"Augarten","year":"2008","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0039-1696726","article-title":"Growth and Nutrition in Cystic Fibrosis","volume":"40","author":"Brownell","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2009.09.001","article-title":"Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis","volume":"155","author":"Borowitz","year":"2009","journal-title":"J. Pediatr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","article-title":"High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis","volume":"336","author":"FitzSimmons","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/path.4634","article-title":"Pancreatic pathophysiology in cystic fibrosis","volume":"238","author":"Meyerholz","year":"2016","journal-title":"J. Pathol."},{"key":"ref_59","first-page":"100290","article-title":"Cystic fibrosis-related diabetes: Prevalence, screening, and diagnosis","volume":"27","author":"Khare","year":"2022","journal-title":"J. Clin. Transl. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"ii31","DOI":"10.1136\/gut.52.suppl_2.ii31","article-title":"Chronic pancreatitis and cystic fibrosis","volume":"52","author":"Witt","year":"2003","journal-title":"Gut"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis","volume":"140","author":"Ooi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1542\/peds.2004-1764","article-title":"Pancreatitis among patients with cystic fibrosis: Correlation with pancreatic status and genotype","volume":"115","author":"Weren","year":"2005","journal-title":"Pediatrics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.pcl.2016.04.008","article-title":"Gastrointestinal, Pancreatic, and Hepatobiliary Manifestations of Cystic Fibrosis","volume":"63","author":"Sathe","year":"2016","journal-title":"Pediatr. Clin. N. Am."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Petrocheilou, A., Kaditis, A.G., and Loukou, I. (2020). Pancreatitis in A Patient with Cystic Fibrosis Taking Ivacaftor. Children, 7.","DOI":"10.3390\/children7010006"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1002\/ppul.24353","article-title":"Time for a gut check: Pancreatic sufficiency resulting from CFTR modulator use","volume":"54","author":"Megalaa","year":"2019","journal-title":"Pediatr. Pulmonol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(16)30032-7","article-title":"Partial restoration of pancreatic function in a child with cystic fibrosis","volume":"4","author":"Howlett","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jcf.2017.07.004","article-title":"Pancreatitis and pancreatic cystosis in Cystic Fibrosis","volume":"16","author":"Freeman","year":"2017","journal-title":"J. Cyst. Fibros."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S1569-1993(11)60006-4","article-title":"Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease","volume":"10","author":"Debray","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2004.10.002","article-title":"Liver involvement in cystic fibrosis: Primary organ damage or innocent bystander?","volume":"41","author":"Colombo","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2004.08.006","article-title":"Epidemiology of liver disease in cystic fibrosis: A longitudinal study","volume":"41","author":"Lamireau","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Patel, D., Shan, A., Mathews, S., and Sathe, M. (2022). Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management. Nutrients, 14.","DOI":"10.3390\/nu14051028"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MPG.0000000000001676","article-title":"Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives","volume":"65","author":"Debray","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/jama.2009.1295","article-title":"Genetic modifiers of liver disease in cystic fibrosis","volume":"302","author":"Bartlett","year":"2009","journal-title":"JAMA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"440","DOI":"10.23736\/S0026-4946.20.05895-8","article-title":"Cystic fibrosis-associated liver disease in children","volume":"72","author":"Wasuwanich","year":"2020","journal-title":"Minerva Pediatr."},{"key":"ref_75","first-page":"Cd000222","article-title":"Ursodeoxycholic acid for cystic fibrosis-related liver disease","volume":"9","author":"Cheng","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.29217","article-title":"Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity","volume":"66","author":"Koh","year":"2017","journal-title":"Hepatology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/MCP.0b013e3282f10a16","article-title":"Liver disease in cystic fibrosis","volume":"13","author":"Colombo","year":"2007","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/MCG.0b013e31819e8bbd","article-title":"Hepatobiliary abnormalities and disease in cystic fibrosis: Epidemiology and outcomes through adulthood","volume":"43","author":"Bhardwaj","year":"2009","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1203\/00006450-199610000-00011","article-title":"Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis","volume":"40","author":"Zemel","year":"1996","journal-title":"Pediatr. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clnu.2006.08.002","article-title":"Nutritional status, perceived body image and eating behaviours in adults with cystic fibrosis","volume":"26","author":"Abbott","year":"2007","journal-title":"Clin. Nutr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3476(99)70059-4","article-title":"Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen","volume":"135","author":"Feranchak","year":"1999","journal-title":"J. Pediatr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/ajcn\/63.5.717","article-title":"Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals","volume":"63","author":"Tuchschmid","year":"1996","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR Modulators on Anthropometric Parameters in Individuals with Cystic Fibrosis: An Evidence Analysis Center Systematic Review","volume":"121","author":"Bailey","year":"2021","journal-title":"J. Acad. Nutr. Diet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/pedi.12026","article-title":"Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: A small pilot study","volume":"14","author":"Bellin","year":"2013","journal-title":"Pediatr. Diabetes"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto","volume":"41","author":"Corey","year":"1988","journal-title":"J. Clin. Epidemiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajcn\/55.1.108","article-title":"Nutritional assessment and management in cystic fibrosis: A consensus report. The Consensus Committee","volume":"55","author":"Ramsey","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0261-5614(98)80061-7","article-title":"Nutrition in adults with cystic fibrosis","volume":"17","author":"Bell","year":"1998","journal-title":"Clin. Nutr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0140-6736(86)90772-5","article-title":"Chronic jejunostomy feeding with a non-elemental formula in undernourished patients with cystic fibrosis","volume":"1","author":"Boland","year":"1986","journal-title":"Lancet"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0022-3476(94)70312-4","article-title":"Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis","volume":"124","author":"Steinkamp","year":"1994","journal-title":"J. Pediatr."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(86)80695-3","article-title":"Nutritional rehabilitation in cystic fibrosis: Controlled studies of effects on nutritional growth retardation, body protein turnover, and course of pulmonary disease","volume":"109","author":"Shepherd","year":"1986","journal-title":"J. Pediatr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2019.10.004","article-title":"Prevalence and factors associated with overweight and obesity in adults with cystic fibrosis: A single-center analysis","volume":"19","author":"Harindhanavudhi","year":"2020","journal-title":"J. Cyst. Fibros."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Bhattacharya, R., Blankenheim, Z., Scott, P.M., and Cormier, R.T. (2022). CFTR and Gastrointestinal Cancers: An Update. J. Pers. Med., 12.","DOI":"10.3390\/jpm12060868"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: A systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(18)30250-X","article-title":"Cystic fibrosis: A gastrointestinal cancer syndrome","volume":"19","author":"Slae","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2017.12.012","article-title":"Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations","volume":"154","author":"Hadjiliadis","year":"2018","journal-title":"Gastroenterology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/21\/15766\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:14:25Z","timestamp":1760130865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/21\/15766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":95,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["ijms242115766"],"URL":"https:\/\/doi.org\/10.3390\/ijms242115766","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}